AMG 595, an Anti-EGFRvIII Antibody–Drug Conjugate, Induces Potent Antitumor Activity against EGFRvIII-Expressing GlioblastomaKevin J. Hamblett, William C. Fanslow, Hua Liu et al.|Molecular Cancer Therapeutics|2015Cited by 99
Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma ModelMao Ouyang, Behnam Badie, Ethan E. White et al.|PLoS ONE|2016Cited by 47